$MTNB News Article - Matinas BioPharma Announces U
Post# of 63
(Total Views: 224)
Posted On: 12/16/2021 8:06:06 AM
$MTNB News Article - Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Fourth and Final Cohort of Patients in the EnACT Trial of MAT2203 (Oral Amphotericin 
for the Treatment of Cryptococcal Meningitis https://marketwirenews.com/news-releases/mati...17771.html
for the Treatment of Cryptococcal Meningitis https://marketwirenews.com/news-releases/mati...17771.html 
(0)
(0)Matinas BioPharma Holdings (MTNB) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼